The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Factors for Glaucoma Progression and the Effect of Treatment: The Early Manifest Glaucoma Trial
Abstract
OBJECTIVE: To assess factors for progression in the Early Manifest Glaucoma Trial (EMGT), including the effect of EMGT treatment. SETTING/PARTICIPANTS: Two hundred fifty-five open-angle glaucoma patients randomized to argon laser trabeculoplasty plus topical betaxolol or no immediate treatment (129 treated; 126 controls) and followed up every 3 months. METHODS: Progression was determined by perimetric and photographic optic disc criteria. Patient-based risk of progression was evaluated using Cox proportional hazard regression models and was expressed as hazard ratios (HR) with 95% confidence intervals (95% CI). RESULTS: After 6 years, 53% of patients progressed. In multivariate analyses, progression risk was halved by treatment (HR = 0.50; 95% CI, 0.35-0.71). Predictive baseline factors were higher intraocular pressure (IOP) (ie, the higher the baseline IOP, the higher the risk), exfoliation, and having both eyes eligible (each of the latter 2 factors doubled the risk), as well as worse mean deviation and older age. Progression risk decreased by about 10% with each millimeter of mercury of IOP reduction from baseline to the first follow-up visit (HR = 0.90 per millimeter of mercury decrease; 95% CI, 0.86-0.94). The first IOP at that visit (3 months' follow-up) was also related to progression (HR = 1.11 per millimeter of mercury higher; 95% CI, 1.06-1.17), as was the mean IOP at follow-up (HR = 1.13 per millimeter of mercury higher; 95% CI, 1.07-1.19). The percent of patient follow-up visits with disc hemorrhages was also related to progression (HR = 1.02 per percent higher; 95% CI, 1.01-1.03). No other factors were identified. CONCLUSIONS: Patients treated in the EMGT had half of the progression risk of control patients. The magnitude of initial IOP reduction was a major factor influencing outcome. Progression was also increased with higher baseline IOP, exfoliation, bilateral disease, worse mean deviation, and older age, as well as frequent disc hemorrhages during follow-up. Each higher (or lower) millimeter of mercury of IOP on follow-up was associated with an approximate 10% increased (or decreased) risk of progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kass, M. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.701 · Cited by 3,705
Heijl, A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1268 · Cited by 3,320
(2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00538-9 · Cited by 2,780
Gordon, M. O. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.714 · Cited by 2,626
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
Regression analysis of multivariate incomplete failure time data by modeling marginal distributions
Wei, L. J., Lin, D. Y., & Weissfeld, L. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478873 · Cited by 1,868
Covariance Analysis of Censored Survival Data
Breslow, N. (1974) · Biometrics · doi:10.2307/2529620 · Cited by 1,763
(1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00223-2 · Cited by 1,599
The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
(1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00272-4 · Cited by 1,301
Lichter, P. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00873-9 · Cited by 1,178
Risk factors for progression of visual field abnormalities in normal-tension glaucoma
Drance, S., Anderson, D. R., & Schulzer, M. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00964-3 · Cited by 790
Lens Opacities Classification System II (LOCS II)
Chylack, L. T. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070020053028 · Cited by 567
Leske, M. C., Heijl, A., Hyman, L., & Bengtsson, B. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90497-9 · Cited by 566
Self-citationMusch, D. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90147-1 · Cited by 402
Åsman, P. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080180084033 · Cited by 295
(1994) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)90046-9 · Cited by 246
Fluorouracil Filtering Surgery Study One-Year Follow-up
FOURMAN, S., FRANKS, W., & HITCHINGS, R. (1990) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70706-8 · Cited by 225
The Quality of Medical Evidence: Implications for Quality of Care
Eddy, D. M., & Billings, J. (1988) · Health Affairs · doi:10.1377/hlthaff.7.1.19 · Cited by 190
Rossetti, L. M., Marchetti, I., Orzalesi, N., Scorpiglione, N., Torri, V., & Liberati, A. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090010100034 · Cited by 100
Clinical Factors Associated with Progression of Normal-Tension Glaucoma
Ishida, K., Yamamoto, T., & Kitazawa, Y. (1998) · Journal of Glaucoma · doi:10.1097/00061198-199812000-00004 · Cited by 97
Prevalence of open‐angle glaucoma in central Sweden: The Tierp Glaucoma Survey
Ekström, C. (1996) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1996.tb00052.x · Cited by 71
Cited by
Weinreb, R. N., & Khaw, P. T. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16257-0 · Cited by 2,222
Predictors of Long-term Progression in the Early Manifest Glaucoma Trial
Leske, M. C., Heijl, A., Hyman, L., Bengtsson, B., Dong, L., & Yang, Z. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.016 · Cited by 1,363
Self-citationQuigley, H. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61423-7 · Cited by 1,121
The molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
Optical Coherence Tomography Angiography of Optic Disc Perfusion in Glaucoma
Jia, Y., Wei, E., Wang, X., Zhang, X., Morrison, J. C., Parikh, M., Lombardi, L. H., Gattey, D. M., Armour, R. L., Edmunds, B., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.01.021 · Cited by 740
Metadata
- Authors
- Leske, M. C.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2003-01-01
- Volume
- 121
- Issue
- 1
- Pages
- 48
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2147093603
- Cited by
- 2,030
- References
- 21
- FWCI
- 55.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.